JLM-BioCity announces:
June 14, 2018 18:30

You have been working hard to advance the development of your technology. You are now thinking about your first (or next) financing round. Is this the best time to approach investors? If so, what would be the best way to do this so that you stand out from other companies and get noticed?

We have assembled a group of experts who will help you answer these and other questions.

These include:

– Guido Pardo Roques – former president of Philips Electronics Israel
– Nurit Tweezer – Zaks – formerly talent scout for Sanofi
– Miron Derchansky – Head, Leo Pharma’s innovation lab

Gerry Stoch, Director, New York State Representative Office, Israel will talk about the new $47 million Bio Initiative of the State of New York and how Israeli life science companies can get involved.

Ms. Louise VIBJERG, COMMERCIAL COUNSELOR / HEAD OF TRADE & INNOVATION OFFICER at the Danish Embassy, Israel, will shortly present interest of Danish Life Science corporates in meeting with early stage innovative Healthcare companies and technologies.

JLM-BioCity is delighted to announce that this event is sponsored by the Azrieli College of Engineering.

The event will take place in room C-102 (floor MINUS 1) bldg 3 at Azrieli College of Engineering.

RVSP to reserve your place AND SENT YOUR NAME IN HEBREW AND CAR LICENCE to good.o.joe@gmail.com

About our invited speakers:
GUIDO PARDO ROQUES – former President & CEO, Philips Medical Systems Technologies (PMSTL)
Guido was til April 2018 the president and CEO of Philips Israel and CEO of Philips Medical System Technologies. He is also Chairman of the Medical Equipment forum, Board Member of IAESI (Israel Association of Electronics and Software Industries), Board Member of IATI (Israel Advanced Technology Industries) and member of the Technion Board of Governors.

Guido joined Elscint’s CT Division in 1980; in 1988 he was appointed to Project Manager of the CT Twin, the world’s first multislice scanner, a breakthrough product that changed the CT imaging landscape. In 1993, he was appointed to R&D Manager of Elscint CT and in this function, he was one of the leaders that positioned the Haifa facility as the major CT detection site in the world. In 2001 the activity was acquired by Philips.

Guido holds BSc and MSc from the Technion and MBA from the Haifa University.

NURIT TWEEZER – ZAKS – Manager, Scouting and Partnering for Sanofi

Nurit founded and was the leader of the medical department at Sanofi Israel. She went on to become the Global Established Medical Product Lead at Sanofi, where she carries out scientific and strategic evaluation of technologies both in early research and business development stages as well as develops innovative solutions for established products.

Nurit is an M.D. Doctor in Medicine from Ben Gurion University and an MBA from the Kellogg School of Management, Northwestern U.

MIRON DERCHANSKY, PhD, MBA – Head, Leo Pharma Innovation Lab (Tel Aviv)
Focusing on digital health solutions for people living with chronic skin conditions. With a technology team of over 100 people working in Copenhagen, San Francisco, Toronto, London and now Tel Aviv, the LEO iLab both builds and invests in solutions in areas like telemedicine, diagnostic support tools, novel computer vision & machine learning tech, medication adherence, mental health and diet & nutrition.

Before joining LEO, Miron held multiple executive positions focused on strategy and innovation, including with LexisNexis Canada and Monitor Deloitte, where he helped Fortune100 companies, governments and entrepreneurs build and execute growth strategies. He is the founder of five startups in the neurotech, software and media space. with an MBA and PhD from the University of Toronto.